| Product Code: ETC12773616 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Despite a high Herfindahl-Hirschman Index indicating concentrated import market for NSAIDs in Togo, the top exporting countries like France, India, China, USA, and Denmark continue to contribute significantly. The negative Compound Annual Growth Rate (CAGR) from 2020-2024 and a decline in the growth rate from 2023-2024 suggest a challenging market environment. Togo may need to diversify its import sources and implement strategies to stimulate growth in the NSAIDs market for a more balanced and sustainable industry performance.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Overview |
3.1 Togo Country Macro Economic Indicators |
3.2 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, 2021 & 2031F |
3.3 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Industry Life Cycle |
3.4 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Porter's Five Forces |
3.5 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of inflammatory conditions in Togo |
4.2.2 Growing awareness about the benefits of non-steroidal anti-inflammatory drugs (NSAIDs) in managing pain and inflammation |
4.2.3 Rising healthcare expenditure and improving access to healthcare facilities |
4.3 Market Restraints |
4.3.1 Potential side effects associated with long-term use of NSAIDs |
4.3.2 Stringent regulatory requirements for the approval and marketing of NSAIDs in Togo |
5 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Trends |
6 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By Types |
6.1 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By OTC NSAIDs, 2021 - 2031F |
6.1.4 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Prescription NSAIDs, 2021 - 2031F |
6.1.5 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Topical NSAIDs, 2021 - 2031F |
6.1.6 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Ibuprofen, 2021 - 2031F |
6.2.3 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Celecoxib, 2021 - 2031F |
6.2.4 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Diclofenac Gel, 2021 - 2031F |
6.2.5 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Naproxen, 2021 - 2031F |
6.3 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.3.3 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.5 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Homecare, 2021 - 2031F |
6.4 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Pain Relief, 2021 - 2031F |
6.4.3 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Arthritis Treatment, 2021 - 2031F |
6.4.4 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Musculoskeletal Pain, 2021 - 2031F |
6.4.5 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Fever Reduction, 2021 - 2031F |
7 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Import-Export Trade Statistics |
7.1 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Export to Major Countries |
7.2 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Imports from Major Countries |
8 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Key Performance Indicators |
8.1 Average prescription rate of NSAIDs per patient visit |
8.2 Number of healthcare facilities offering NSAIDs as a treatment option |
8.3 Patient satisfaction levels with the effectiveness of NSAIDs in managing their conditions |
9 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Opportunity Assessment |
9.1 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Competitive Landscape |
10.1 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenue Share, By Companies, 2024 |
10.2 Togo Non Steroidal Anti Inflammatory Drugs NSAIDs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |